Failure Case Library

Non-specific Antibody Binding via Fc Receptors

Elevated background staining on myeloid cells (monocytes, macrophages, dendritic cells, granulocytes) in bone marrow, blood, spleen, or in vitro myeloid cultures. False-positive signals not blocked by standard washing.

Receptor Downregulation After Cell Stimulation

Surface receptor staining (e.g., TCR/CD3 complex) becomes weak or negative after antibody or cytokine stimulation of cultured cells. Expected positive populations appear diminished.

Antibody Epitope Destroyed by Enzymatic Digestion

Loss of antibody binding after tissue dissociation or adherent cell detachment. Anti-cadherin and other surface markers show negative or weak staining despite expected expression.

💡 4 causes ✓ 6 fixes

Surface Epitope Masked After Fixation

Surface marker staining fails or weakens when performed after cell fixation. Some antibody clones lose binding capacity to fixed cells.

💡 4 causes ✓ 6 fixes

Autofluorescence Interferes with Detection Channels

High background fluorescence observed in BV421, FITC, and PE channels, particularly with myeloid cells (monocytes, macrophages, neutrophils, eosinophils). Positive signal difficult to distinguish from cellular autofluorescence.

Surface Receptor Loss Due to Temperature Exposure

Chemokine and cytokine receptors (CCR7, CD115/M-CSFR) show unexpectedly low or negative staining. Signal loss occurs after sample handling at non-optimal temperatures.

Rare Cell Population Incorrectly Gated or Missed

Target rare immune cell subsets (e.g., dendritic cells, innate lymphoid cells, hematopoietic progenitors) appear overestimated or masked by abundant terminally differentiated cells. Gating on single markers yields incorrect population percentages (e.g., 4.5% vs. true 1.2% DCs).

Surface Receptor Downregulation After Temperature or Stimulation

Loss of surface staining intensity or complete absence of expected surface markers (chemokine receptors CCR7, cytokine receptors CD115/M-CSFR, TCR/CD3 complex) after exposure to non-optimal temperatures or antibody/cytokine stimulation, leading to underestimation of target population frequencies.

Antibody Epitope Alteration by Fixation

Surface marker staining intensity decreases or disappears when antibodies are applied after cell fixation, or intracellular targets remain undetectable despite using fixation/permeabilization buffers, indicating epitope conformational changes or masking.

Elevated Autofluorescence in Myeloid and Granular Cells

High background fluorescence detected in shorter wavelength channels (BV421, FITC, PE), particularly in larger granular cells such as monocytes, neutrophils, eosinophils, macrophages, and dendritic cells, compromising signal-to-noise ratio for true positive events.

Nonspecific Antibody Binding via Fcγ Receptors

Elevated false-positive staining observed in myeloid-enriched samples (bone marrow, blood, spleen, in vitro myeloid differentiation cultures) due to antibody Fc region binding to Fcγ receptors on monocytes, macrophages, dendritic cells, and granulocytes.

Antibody Epitope Destruction by Enzymatic Digestion

Antibody fails to recognize target antigen on cells after enzymatic tissue dissociation or adherent cell detachment, resulting in absent or dramatically reduced staining intensity for markers like cadherins despite confirmed gene/protein expression by other methods.

Rare Cell Populations Overwhelmed by Abundant Cells

Target rare immune cell populations (e.g., dendritic cells, innate lymphoid cells, hematopoietic progenitors) cannot be adequately resolved or quantified due to overwhelming signals from abundant terminally differentiated cells in lymphoid tissues or non-lymphoid tissues.